South San Francisco, CA, United States of America

Brian Salvatore Safina

USPTO Granted Patents = 46 (Patent Applications = 48)

CIPO Patents = 4 (Patent Applications = 19)

EPO Patents = 21 (Patent Applications = 48)

Average Co-Inventor Count = 9.2

ph-index = 9

Forward Citations = 283(Granted Patents)

Location History:

San Francisco, CA (US) (2015)
Belmont, CA (US) (2019)
Redwood City, CA (US) (2010 - 2023)
South San Francisco, CA (US) (2014 - 2023)

Company Filing History:

Xenon Pharmaceuticals Inc.

F. Hoffmann-la Roche Ag

Bolt Biotherapeutics, Inc.

patents

9. 1 out of 1

Hoffman-laroche, Inc. (us Only)

patent

10. 1 out of 1

F. Hoffman-laroche, Ag (ex-us)

patent

where one patent can have more than one assignee

Years Active: 2010-2024

Loading Chart...

46 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12139496 - Therapeutic compounds and methods of use thereof (2024-11-12),

2. 11692043 - Peptidomimetic compounds and antibody-drug conjugates thereof (2023-07-04),

3. 11654199 - Thienoazepine immunoconjugates, and uses thereof (2023-05-23),

4. 11149002 - Therapeutic compounds and methods of use thereof (2021-10-19),

5. 11130726 - Therapeutic compounds and methods of use thereof (2021-09-28),

6. 10947251 - Therapeutic compounds and methods of use thereof (2021-03-16),

7. 10899732 - Substituted benzamides useful as sodium channel blockers (2021-01-26),

8. 10787446 - Therapeutic compounds and methods of use thereof (2020-09-29),

9. 10711004 - Oxadiazole transient receptor potential channel inhibitors (2020-07-14),

10. 10632210 - Peptidomimetic compounds and antibody-drug conjugates thereof (2020-04-28),

11. 10544215 - 1-(Chloromethyl)-2,3-dihydro-1H-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment (2020-01-28),

12. 10533058 - Peptidomimetic compounds and antibody-drug conjugates thereof (2020-01-14),

13. 10526285 - Therapeutic compounds and methods of use thereof (2020-01-07),

14. 10442836 - 1-(chloromethyl)-2,3-dihydro-1H-benzo[E]indole dimer antibody-drug conjugate compounds, and methods of use and treatment (2019-10-15),

15. 10179767 - Substituted benzamides and methods of use thereof (2019-01-15),

Title: The Innovation Journey of Brian Salvatore Safina

Introduction:

Brian Salvatore Safina, a prolific inventor based in South San Francisco, CA, has made significant contributions to the field of pharmaceuticals with a total of 45 patents to his name. His innovative spirit and dedication to advancing cancer therapy have earned him recognition in the industry.

Latest Patents:

Safina's recent patents include groundbreaking inventions such as peptidomimetic compounds and antibody-drug conjugates for the prevention and treatment of cancer. Additionally, he has developed thienoazepine immunoconjugates that show promising results in the fight against cancer. These inventions demonstrate Safina's commitment to pushing the boundaries of medical science.

Career Highlights:

Throughout his career, Safina has worked with renowned companies such as Genentech, Inc. and Xenon Pharmaceuticals Inc. His time at these organizations has allowed him to collaborate with top experts in the field and refine his innovative ideas. Safina's dedication to research and development has led to the successful implementation of his patented inventions in real-world medical applications.

Collaborations:

Safina's collaborations with industry experts like Daniel P Sutherlin and Sultan Chowdhury have been instrumental in transforming his innovative concepts into tangible products. Together, they have spearheaded projects that have the potential to revolutionize cancer treatment and improve patient outcomes. Safina's ability to work effectively in a team is a testament to his leadership and vision in the pharmaceutical industry.

Conclusion:

Brian Salvatore Safina's remarkable journey as an inventor showcases his unwavering commitment to innovation and his passion for improving healthcare through groundbreaking inventions. With numerous patents to his name and a legacy of collaboration with industry leaders, Safina continues to inspire the next generation of inventors in the field of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.